HDAC4 and B-cell non-Hodgkin lymphoma: Several studies have been focusing on unveiling the miR-155 oncogenic role in B-cell lymphomas, reporting that its targets NIAM, histone deacetylase 4 (HDAC4), and SHIP1 [38,39,40].